Time course for benefit and risk of ticagrelor and aspirin in acute ischemic stroke or transient ischemic attack

Y Wang, Y Pan, H Li, P Amarenco, H Denison… - Neurology, 2022 - AAN Enterprises
Background and Objectives The goal of this work was to investigate the short-term time-
course benefit and risk of ticagrelor with aspirin in acute mild-moderate ischemic stroke or …
被引用次数：8 相关文章
[HTML] nih.gov

[HTML][HTML] Time Course for Benefit and Risk of Ticagrelor and Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack

Y Wang, Y Pan, H Li, P Amarenco, H Denison… - Neurology, 2022 - ncbi.nlm.nih.gov
Methods In an exploratory analysis of the THALES trial, we evaluated the cumulative
incidence of irreversible efficacy and safety outcomes at different time points during the 30 …

Time Course for Benefit and Risk of Ticagrelor and Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack.

Y Wang, Y Pan, H Li, P Amarenco, H Denison… - Neurology, 2022 - europepmc.org
Methods In an exploratory analysis of the THALES trial, we evaluated the cumulative
incidence of irreversible efficacy and safety outcomes at different time points during the 30 …

Time Course for Benefit and Risk of Ticagrelor and Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack

Y Wang, Y Pan, H Li, P Amarenco, H Denison… - …, 2022 - ingentaconnect.com
Background and Objectives The goal of this work was to investigate the short-term time-
course benefit and risk of ticagrelor with aspirin in acute mild-moderate ischemic stroke or …

Time Course for Benefit and Risk of Ticagrelor and Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack

Y Wang, Y Pan, H Li, P Amarenco, H Denison… - Neurology, 2022 - diva-portal.org
Methods In an exploratory analysis of the THALES trial, we evaluated the cumulative
incidence of irreversible efficacy and safety outcomes at different timepoints during the 30 …

Time Course for Benefit and Risk of Ticagrelor and Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack

Y Wang, Y Pan, H Li, P Amarenco, H Denison… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Background and objectives The goal of this work was to investigate the short-term time-
course benefit and risk of ticagrelor with aspirin in acute mild-moderate ischemic stroke or …

Time Course for Benefit and Risk of Ticagrelor and Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack

Y Wang, Y Pan, H Li, P Amarenco, H Denison… - …, 2022 - hsrc.himmelfarb.gwu.edu
OBJECTIVES: To investigate the short-term time course benefit and risk of ticagrelor with
aspirin in acute mild-moderate ischemic stroke or high-risk transient ischemic attack (TIA) in …
[PDF] diva-portal.org

[PDF][PDF] Neurology Publish Ahead of Print

2022 - diva-portal.org
Methods In an exploratory analysis of the THALES trial, we evaluated the cumulative
incidence of irreversible efficacy and safety outcomes at different timepoints during the 30 …